In this dynamic presentation Dr. Mimi Secor DNP, FNP-BC, FAANP, FAAN, presents current challenges and trends in contraceptive management. Learners will understand medical eligibility criteria and the latest contraceptive research for prescribing considerations. Unique patient considerations, efficacy, patient needs, and other critical prescribing points are reviewed. | 1.50 credits CE/CME category 1 credits (1.50 Pharmacology) | $40

This session will review the current epidemiology of sexually transmitted infections (STIs) in the United States and outline an evidence-based diagnostic approach for identifying these conditions. Participants will learn best practices for managing the most common STIs in women, including herpes simplex virus, chlamydia, gonorrhea, pelvic inflammatory disease (PID), cervicitis. | 1.50 credits CE/CME category 1 credits (1.50 Pharmacology) | $40

Cervical cancer prevention has changed significantly in recent years with less frequent screening and with the approval of HPV primary screening every 5 years, with a reflex Pap done only if the HPV test is positive. Additionally, co-testing with Pap and HPV every 5 years or Pap alone every 3 years remains an option. This session will review the appropriate use of Pap testing, the rationale for HPV testing along with the Pap (co-testing) in women 30 and older and the use of HPV testing as a primary screen (stand-alone test) in women 25 and older by two of the FDA approved HPV tests. There will be a discussion of the American Cancer Society Guidelines for screening and a review of the 2019 ASCCP Risk-Based Management Consensus Guidelines for management of abnormal screening and subsequent follow-up with case studies. These guidelines are a shift from results-based to risk-based management relative to the risk of an existing CIN 3 (pre-cancer). | 1.0 CE/CME category 1 credits (0 Pharmacology) | $27.50

This presentation will review the increasing prevalence of syphilis, including which populations of patients should be tested for this infection. The syphilis testing cascade will be discussed, including guidance on how to ensure that an active infection has been completely treated and how often patients need follow-up and tests of reinfection. The current penicillin shortage will be discussed when the most appropriate, evidenced-based treatment |1.0 CE/CME (0.50 Pharmacology) | $30

Globally, maternal deaths during pregnancy and postpartum are a public health crisis. In the United States, approximately 1,200 women die each year during childbirth and postpartum periods due to pregnancy related complications. Global, National, and State surveillance reports have deemed that 80% of these deaths are preventable. The U.S. maternal morbidity and mortality rates are the highest among industrialized nations worldwide. The current data suggests that this trend is worsening despite significant advancements in healthcare practices and technologies. The prevalence of near deaths far exceeds the maternal deaths and pose significant morbidity for women and infants. Access to care, implicit bias, and systemic racism are the leading causes of maternal health disparities. In addition, the maternity provider workforce supply is on average 5 to 6 times less in comparison to other developed countries who have low maternal mortality rates. This presentation will explore the history of maternal health disparities, causes of maternal deaths, and proposed solutions to address the maternal health crisis in the United States. | 1.50 CE/CME category 1 credits (0.50 Pharmacology) | $35

Preventing unintended pregnancy by providing the most effective contraceptive methods without barriers is more important then ever. Long-acting reversible contraception (LARC) is the safest and most effective contraception available. The implant and IUDs also have the highest patient satisfaction and continuation rates, and yet there remain many barriers to patients accessing these contraceptive methods. We will review common barriers and how to avoid them in your practice. We will discuss how to provide patient centered counselling about LARC methods, tools to provide the most up to date evidence-based care, and how to remove operational barriers in your practice. Whether you don’t provide LARC yet and want to hone your counseling skills and are interested in free training opportunities; or you are an experienced provider of LARC and want to update your practice and learn some helpful tips and tricks-There is something for everyone in this presentation. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

Almost half of all pregnancies in the U.S. are unintended and 1 in 4 women will have an abortion in their lifetime. Despite losing the right to abortion, people still need them. We will examine the current landscape of abortion access post-Roe, how and where people are accessing abortion care and what resources you can offer your patients to help them access the care they need. You will gain an in depth understanding of medication abortion: various evidence-based regimens, delivery systems like telehealth, warnings signs of a complication, overall safety and efficacy, and management of common problems post-abortion. We will also examine the role of self-managed abortion in this new landscape and dispel common myths. This lecture will leave you feeling confident and equipped to advocate and care for your patients before and after an abortion regardless of where you or they live. | 1.50 CE/CME category 1 credits (1.0 Pharmacology) | $35

Discuss the epidemiology, complex pathophysiology, associated risks and complications. List symptoms, signs & explain diagnostic work-up including the complex differential process. Describe evidence-based management approaches including pharmacologic and non-pharmacologic treatments and lifestyle modifications. | 1.5 CE/CME category 1 credits (1.00 Pharmacology) | $35

This session explores the clinical strategies and decision-making processes involved in the use of traditional and bioidentical hormone replacement therapies (HRT) for the management of menopausal symptoms. Participants will gain a comprehensive understanding of the benefits, risks, and controversies surrounding both approaches, enabling more informed and individualized care for women transitioning through menopause. | 1.5 CE/CME category 1 credits (1.0 Pharmacology) | $40

Human trafficking (HT) impacts over 50 million individuals worldwide. Although an intersection between HT victims and HCPs exists, many victims seen by HCPs remain unidentified. This training will focus on human trafficking, risk factors associated with human trafficking, adverse childhood experiences, and the role of the healthcare provider. | 1.0 CE/CME category 1 credits (0 Pharmacology) | $27.5